Mass spectrometry methods measured androgen and estrogen concentrations during pregnancy and in newborns of mothers with polycystic ovary syndrome.

Eur J Endocrinol

Division of Reproductive MedicineDepartment of Obstetrics and Gynaecology, VU University Medical Center (VUmc), Gebouw Zuid, Amstelveenseweg 601, 1081 JC Amsterdam, The NetherlandsARUP Institute for Clinical and Experimental PathologySalt Lake City, Utah, USADepartment of PathologyUniversity of Utah School of Medicine, Salt Lake City, USADepartment of MedicineUniversity of Utah School of Medicine, Salt Lake City, USAHomerton Fertility CentreHomerton University Hospital, London, UK.

Published: January 2016

Objective: Little is known about the aetiology of polycystic ovary syndrome (PCOS). Some suggest that elevated maternal androgens during gestation play a causative role. This implies placental passage of androgens during pregnancy. The aim of this study is to compare androgen and estrogen concentrations in maternal serum during pregnancy and in umbilical cord blood, between mothers with PCOS and their offspring compared to controls.

Design: Prospective case-control study.

Methods: Maternal blood samples were collected around 20 weeks of gestation and at delivery. Umbilical cord blood was also taken at delivery. Androgens (testosterone (T), androstenedione (ADION), dehydroepiandrostenedione (DHEA)) and estrogens (estrone (E1), estradiol (E2), estriol (E3)) were measured using the liquid chromatography tandem mass spectrometry (LC-MS/MS) methods.

Results: At 20 weeks of gestation: T (P=0.019) and ADION (P=0.034) were higher in the PCOS mothers (pregnant with a girl), whereas DHEA, E1, E2, and E3 were not different. Maternal concentration at birth: T (P=0.004) and ADION (P=0.009) were also higher in the subgroup of PCOS mothers that were pregnant with a girl compared to the girl pregnancy controls. DHEA, E1, E2 and E3 were not different. In umbilical cord blood, no differences were found for T, ADION, DHEA, E2, E3, and AMH between the PCOS mothers and the controls respectively. E1 was lower in girls from PCOS mothers (P=0.007).

Conclusions: Despite elevated maternal androgen concentrations during pregnancy in PCOS mothers, offspring showed no signs of elevated androgen concentrations in cord blood at birth using the latest highly specific LC-MS/MS methods.

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-15-0699DOI Listing

Publication Analysis

Top Keywords

pcos mothers
20
cord blood
16
umbilical cord
12
mass spectrometry
8
androgen estrogen
8
estrogen concentrations
8
concentrations pregnancy
8
polycystic ovary
8
ovary syndrome
8
elevated maternal
8

Similar Publications

Unexpected delivery: cryptic pregnancy.

BMJ Case Rep

November 2024

Department of Obstetrics and Gynaecology, Leighton Hospital, Mid Cheshire Hospitals NHS Foundation Trust, Middlewich Road, Crewe, CW1 4QJ, UK.

Cryptic pregnancy was first described in the early 17th century and occurs when the pregnant person is unaware of their pregnant state and discovers this late in pregnancy or when labour starts. Historically, the term 'concealed pregnancy' has been used synonymously. In a concealed pregnancy, the patient is aware of their pregnancy but chooses to hide it.

View Article and Find Full Text PDF

Is metformin safe in pregnancy: a focus on offspring outcomes.

Expert Opin Drug Saf

November 2024

Theodore E. Woodward Professor of Medicine, Chairman, Department of Medicine, University of Maryland School of Medicine, Physician-in-Chief, University of Maryland Medical Center, Baltimore, MD, USA.

Article Synopsis
  • Metformin has been a staple in treating type 2 diabetes for years and is also used off-label for conditions like gestational diabetes and polycystic ovarian syndrome due to its insulin-sensitizing properties.
  • In 2022, it became the only oral medication approved by the European Union for managing diabetes during pregnancy, showing safety and benefits for mothers while crossing the placenta to the baby.
  • Benefits for mothers include reduced weight gain and lower risk of pre-eclampsia; however, long-term effects on their children are still uncertain, necessitating further research on potential concerns like small-for-gestational-age (SGA) outcomes.
View Article and Find Full Text PDF

Purpose: To investigate the effects of fresh embryo transfer and frozen-thawed embryo transfer on perinatal outcomes among patients with PCOS.

Method: Patients who underwent in vitro fertilization and embryo transfer at the reproductive medicine center of the Affiliated Hospital of Guangdong Medical University from February 2013 to March 2021 were retrospectively analyzed. Patients were divided into the fresh embryo transfer group and frozen-thawed embryo transfer group according to whether fresh embryo transfer was performed.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to compare pregnancy outcomes between women with PCOS and a control group, assessing maternal-fetal health and birth outcomes through data collected from 2017 to 2022.
  • - Results showed women with PCOS had higher incidences of preeclampsia (12.3% vs. 8.1%) and gestational diabetes (18.7% vs. 9.8%) compared to the control group, highlighting increased risks associated with PCOS.
  • - However, there were no significant differences in low birth weight or preterm delivery, indicating the complexity of PCOS's impact on pregnancy and the need for further research to improve health outcomes for mothers and babies.
View Article and Find Full Text PDF
Article Synopsis
  • Women who had gestational diabetes (GDM) in their first pregnancy are likely to have it again in their next, but even those without previous GDM can develop it later.
  • A study involving 759 women examined their GDM history in two pregnancies and categorized them based on their glucose tolerance status.
  • Key predictors for developing GDM included family history, pregravid obesity, and specific glucose levels during the first OGTT, highlighting that higher glucose levels in the first pregnancy significantly raise the risk of GDM in subsequent pregnancies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!